Abbott delivers double-digit underlying organic growth in 2021 and sees >$6bn in COVID-19 Revenues
Abbott has high exposure to emerging markets and consumer-directed businesses, driving the potential for sustainable double-digit earnings growth
Leverage opportunities are visible across multiple business segments including Nutrition, Diagnostics, and EPD
Abbott has high exposure to emerging markets and consumer-directed businesses, driving the potential for sustainable double-digit earnings growth
Leverage opportunities are visible across multiple business segments including Nutrition, Diagnostics, and EPD